Gilgamesh Pharmaceuticals
Andrew Kruegel is a Discovery Chemist & Co-Founder and a Medicinal chemist and entrepreneur. Andrew is a Chief Scientific Officer and co-founder of Kures, a VC-backed preclinical biotech company developing novel psychoactive compounds for central nervous system disorders. He was a former research scientist at Columbia University.
Gilgamesh Pharmaceuticals
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.